BNY Mellon Global Real Return Fund - Class A
DRRAX
NASDAQ
| Weiss Ratings | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BNY Mellon | |||
| Manager/Tenure (Years) | Aron Pataki (10), Ella Hoxha (0), Nick Pope (0) | |||
| Website | http://www.bny.com/investments | |||
| Fund Information | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BNY Mellon Global Real Return Fund - Class A | |||
| Category | Tactical Allocation | |||
| Sub-Category | Flexible Allocation | |||
| Prospectus Objective | Growth and Income | |||
| Inception Date | May 12, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 3.45% | |||
| Dividend | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.91% | |||
| Asset Allocation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 5.31% | |||
| Stock | 51.57% | |||
| U.S. Stock | 31.26% | |||
| Non-U.S. Stock | 20.31% | |||
| Bond | 21.13% | |||
| U.S. Bond | -12.19% | |||
| Non-U.S. Bond | 33.32% | |||
| Preferred | 0.37% | |||
| Convertible | 0.00% | |||
| Other Net | 21.62% | |||
| Price History | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.11% | |||
| 30-Day Total Return | 1.03% | |||
| 60-Day Total Return | 5.00% | |||
| 90-Day Total Return | 0.57% | |||
| Year to Date Total Return | 6.59% | |||
| 1-Year Total Return | 18.35% | |||
| 2-Year Total Return | 23.65% | |||
| 3-Year Total Return | 34.48% | |||
| 5-Year Total Return | 23.40% | |||
| Price | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $17.63 | |||
| 1-Month Low NAV | $17.44 | |||
| 1-Month High NAV | $17.65 | |||
| 52-Week Low NAV | $15.44 | |||
| 52-Week Low NAV (Date) | May 29, 2025 | |||
| 52-Week High NAV | $17.65 | |||
| 52-Week High Price (Date) | May 26, 2026 | |||
| Beta / Standard Deviation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.11 | |||
| Standard Deviation | 6.95 | |||
| Balance Sheet | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 855.08M | |||
| Operating Ratios | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.19% | |||
| Turnover Ratio | 119.04% | |||
| Performance | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 20.56% | |||
| Last Bear Market Total Return | -2.90% | |||